
ZebraML provides an AI-driven solution for scalable, unbiased, and reproducible analysis of preclinical animal trials. Their AI model processes experimental data from model organisms such as mice, rats, and zebrafish to extract and generalize animal movement patterns. This enables comprehensive comparisons of drug properties based on behavioral changes, overcoming limitations of manual observation and traditional statistical methods. ZebraML supports multiple experimental arena configurations and works with standard animal tracking software outputs. The company focuses on data processing rather than conducting experiments, delivering detailed analytical reports to researchers to accelerate preclinical drug development.

ZebraML provides an AI-driven solution for scalable, unbiased, and reproducible analysis of preclinical animal trials. Their AI model processes experimental data from model organisms such as mice, rats, and zebrafish to extract and generalize animal movement patterns. This enables comprehensive comparisons of drug properties based on behavioral changes, overcoming limitations of manual observation and traditional statistical methods. ZebraML supports multiple experimental arena configurations and works with standard animal tracking software outputs. The company focuses on data processing rather than conducting experiments, delivering detailed analytical reports to researchers to accelerate preclinical drug development.